USD 13.63
(-1.66%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 177.09 Million USD | -6.17% |
2022 | 188.73 Million USD | 25.84% |
2021 | 149.97 Million USD | 9.92% |
2020 | 136.43 Million USD | 10.26% |
2019 | 123.73 Million USD | 24.65% |
2018 | 99.26 Million USD | 29.98% |
2017 | 76.37 Million USD | 33.21% |
2016 | 57.33 Million USD | 34.85% |
2015 | 42.51 Million USD | 36.16% |
2014 | 31.22 Million USD | 24.77% |
2013 | 25.02 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 45.76 Million USD | 4.84% |
2024 Q3 | 47.37 Million USD | -0.52% |
2024 Q2 | 47.62 Million USD | 4.06% |
2023 Q1 | 45.27 Million USD | 2.32% |
2023 Q2 | 46.24 Million USD | 2.14% |
2023 Q4 | 43.65 Million USD | -1.78% |
2023 FY | 177.09 Million USD | -6.17% |
2023 Q3 | 44.44 Million USD | -3.89% |
2022 Q4 | 44.24 Million USD | -8.61% |
2022 Q2 | 47.31 Million USD | -2.98% |
2022 FY | 188.73 Million USD | 25.84% |
2022 Q1 | 48.76 Million USD | 18.8% |
2022 Q3 | 48.41 Million USD | 2.33% |
2021 Q3 | 38.33 Million USD | 5.66% |
2021 Q2 | 36.28 Million USD | 5.73% |
2021 FY | 149.97 Million USD | 9.92% |
2021 Q1 | 34.31 Million USD | -1.57% |
2021 Q4 | 41.04 Million USD | 7.07% |
2020 Q1 | 35.52 Million USD | 1.35% |
2020 Q3 | 33.17 Million USD | 0.92% |
2020 Q4 | 34.86 Million USD | 5.08% |
2020 FY | 136.43 Million USD | 10.26% |
2020 Q2 | 32.87 Million USD | -7.46% |
2019 Q4 | 35.05 Million USD | 8.96% |
2019 FY | 123.73 Million USD | 24.65% |
2019 Q3 | 32.17 Million USD | 13.05% |
2019 Q2 | 28.45 Million USD | 1.41% |
2019 Q1 | 28.06 Million USD | -6.09% |
2018 FY | 99.26 Million USD | 29.98% |
2018 Q2 | 23.21 Million USD | 8.64% |
2018 Q1 | 21.36 Million USD | 1.12% |
2018 Q3 | 24.81 Million USD | 6.89% |
2018 Q4 | 29.87 Million USD | 20.43% |
2017 Q2 | 18.5 Million USD | 7.82% |
2017 Q1 | 17.15 Million USD | -2.86% |
2017 Q3 | 19.58 Million USD | 5.85% |
2017 Q4 | 21.13 Million USD | 7.91% |
2017 FY | 76.37 Million USD | 33.21% |
2016 Q4 | 17.66 Million USD | 14.85% |
2016 FY | 57.33 Million USD | 34.85% |
2016 Q2 | 12.61 Million USD | 8.03% |
2016 Q3 | 15.37 Million USD | 21.93% |
2016 Q1 | 11.67 Million USD | -9.12% |
2015 Q3 | 10.89 Million USD | 7.39% |
2015 Q2 | 10.14 Million USD | 17.48% |
2015 Q1 | 8.63 Million USD | -8.31% |
2015 FY | 42.51 Million USD | 36.16% |
2015 Q4 | 12.84 Million USD | 17.94% |
2014 Q2 | 6.9 Million USD | 0.0% |
2014 FY | 31.22 Million USD | 24.77% |
2014 Q4 | 9.41 Million USD | 18.01% |
2014 Q1 | 6.9 Million USD | 0.0% |
2014 Q3 | 7.97 Million USD | 15.46% |
2013 FY | 25.02 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Acutus Medical, Inc. | 11.22 Million USD | -1477.798% |
Cerus Corporation | 143.15 Million USD | -23.706% |
OrthoPediatrics Corp. | 137.01 Million USD | -29.246% |
PetVivo Holdings, Inc. | 11.36 Million USD | -1458.79% |
Talis Biomedical Corporation | 67.18 Million USD | -163.585% |
Vivos Therapeutics, Inc. | 24.94 Million USD | -609.901% |
Inogen, Inc. | 236.08 Million USD | 24.988% |
Spectral AI, Inc. | 20.86 Million USD | -748.792% |
Nano-X Imaging Ltd. | 55.99 Million USD | -216.253% |
CVRx, Inc. | 76.14 Million USD | -132.581% |
DIH Holding US, Inc. Warrants | 3.52 Million USD | -4919.62% |
Helius Medical Technologies, Inc. | 12.48 Million USD | -1317.984% |
Orthofix Medical Inc. | 667.42 Million USD | 73.466% |
Venus Concept Inc. | 80.47 Million USD | -120.056% |
Accelerate Diagnostics, Inc. | 56.57 Million USD | -213.005% |
Bioventus Inc. | 409.91 Million USD | 56.798% |
BrainsWay Ltd. | 28.01 Million USD | -532.065% |
Envoy Medical, Inc. | 17.89 Million USD | -889.451% |
electroCore, Inc. | 32.03 Million USD | -452.877% |
IceCure Medical Ltd | 16.87 Million USD | -949.372% |
Lucid Diagnostics Inc. | 42.43 Million USD | -317.355% |
Monogram Orthopaedics, Inc. | 17.63 Million USD | -904.32% |
MaxCyte, Inc. | 84.84 Million USD | -108.724% |
NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1326.807% |
Nexalin Technology, Inc. | 5.78 Million USD | -2963.157% |
PAVmed Inc | 64.82 Million USD | -173.176% |
Rapid Micro Biosystems, Inc. | 51.07 Million USD | -246.709% |
RxSight, Inc. | 103.85 Million USD | -70.527% |
Sight Sciences, Inc. | 126.44 Million USD | -40.05% |
SI-BONE, Inc. | 156.35 Million USD | -13.266% |
TELA Bio, Inc. | 84.18 Million USD | -110.356% |
TriSalus Life Sciences, Inc. | 70.05 Million USD | -152.786% |
Treace Medical Concepts, Inc. | 203.36 Million USD | 12.919% |
LivaNova PLC | 843.54 Million USD | 79.006% |
908 Devices Inc. | 68.08 Million USD | -160.123% |
Alphatec Holdings, Inc. | 483.59 Million USD | 63.38% |
Nemaura Medical Inc. | 7.13 Million USD | -2380.696% |
NeuroPace, Inc. | 75.29 Million USD | -135.194% |
LENSAR, Inc. | 33.33 Million USD | -431.234% |
Apyx Medical Corporation | 51.01 Million USD | -247.117% |
Cutera, Inc. | 197.72 Million USD | 10.435% |
STRATA Skin Sciences, Inc. | 24.78 Million USD | -614.628% |
BioSig Technologies, Inc. | 28.53 Million USD | -520.722% |
Anika Therapeutics, Inc. | 191.47 Million USD | 7.512% |
ClearPoint Neuro, Inc. | 36.06 Million USD | -391.104% |
Integra LifeSciences Holdings Corporation | 836.39 Million USD | 78.827% |
Axonics, Inc. | 270.2 Million USD | 34.459% |
Outset Medical, Inc. | 198.77 Million USD | 10.906% |
IRIDEX Corporation | 31.81 Million USD | -456.648% |
PROCEPT BioRobotics Corporation | 180.21 Million USD | 1.735% |
IRadimed Corporation | 30.12 Million USD | -487.9% |
Tivic Health Systems, Inc. | 8.53 Million USD | -1975.621% |
INVO Bioscience, Inc. | 7.85 Million USD | -2155.003% |
Telesis Bio, Inc. | 63.48 Million USD | -178.933% |
Viemed Healthcare, Inc. | 98.45 Million USD | -79.875% |
Varex Imaging Corporation | 224.8 Million USD | 21.222% |
Quipt Home Medical Corp. | 148.66 Million USD | -19.12% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1410.637% |
Pulmonx Corporation | 112.68 Million USD | -57.154% |
Dynatronics Corporation | 9.9 Million USD | -1687.359% |
Modular Medical, Inc. | 17.52 Million USD | -910.28% |
ReShape Lifesciences Inc. | 20.18 Million USD | -777.258% |
Semler Scientific, Inc. | 38.94 Million USD | -354.735% |
InMode Ltd. | 215.68 Million USD | 17.891% |
Bruker Corporation | 1.07 Billion USD | 83.548% |
Cytosorbents Corporation | 48.33 Million USD | -266.371% |
DexCom, Inc. | 1.69 Billion USD | 89.529% |
Align Technology, Inc. | 2.07 Billion USD | 91.473% |
Viveve Medical, Inc. | 22.17 Million USD | -698.683% |
ZimVie Inc. | 275.12 Million USD | 35.632% |
Movano Inc. | 29.69 Million USD | -496.47% |
Cytek Biosciences, Inc. | 137.27 Million USD | -29.009% |
Nexalin Technology, Inc. | 5.78 Million USD | -2963.157% |
DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -4919.62% |
Tandem Diabetes Care, Inc. | 600.92 Million USD | 70.53% |
Profound Medical Corp. | 33.6 Million USD | -427.01% |
Insulet Corporation | 939.9 Million USD | 81.158% |
enVVeno Medical Corporation | 25.23 Million USD | -601.688% |
Surmodics, Inc. | 98.69 Million USD | -79.43% |
iCAD, Inc. | 22.22 Million USD | -696.814% |
Nuwellis, Inc. | 22.61 Million USD | -683.142% |
Biotricity, Inc. | 17.18 Million USD | -930.53% |
iRhythm Technologies, Inc. | 445.88 Million USD | 60.283% |
Aethlon Medical, Inc. | 12.27 Million USD | -1342.41% |
InspireMD, Inc. | 22.95 Million USD | -671.643% |
PAVmed Inc. | 64.82 Million USD | -173.176% |
BIOLASE, Inc. | 34.66 Million USD | -410.926% |
Beyond Air, Inc. | 61.7 Million USD | -187.021% |
FONAR Corporation | 28.6 Million USD | -519.101% |
AxoGen, Inc. | 149.33 Million USD | -18.586% |
Vivani Medical, Inc. | 26.96 Million USD | -556.748% |
Inari Medical, Inc. | 448.59 Million USD | 60.523% |
UFP Technologies, Inc. | 58.08 Million USD | -204.863% |
QT Imaging Holdings, Inc. | 4.92 Million USD | -3493.88% |
Heart Test Laboratories, Inc. | 6.31 Million USD | -2702.847% |
Tenon Medical, Inc. | 16.96 Million USD | -943.682% |
Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -2295.401% |
Co-Diagnostics, Inc. | 44.1 Million USD | -301.543% |
AdaptHealth Corp. | 1.07 Billion USD | 83.572% |
Sintx Technologies, Inc. | 15.2 Million USD | -1065.002% |
NanoVibronix, Inc. | 4.97 Million USD | -3461.07% |
Quanterix Corporation | 118.1 Million USD | -49.951% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1410.637% |
Sensus Healthcare, Inc. | 14.44 Million USD | -1126.229% |
Pacific Biosciences of California, Inc. | 392.66 Million USD | 54.9% |
TransMedics Group, Inc. | 182.82 Million USD | 3.133% |
ReWalk Robotics Ltd. | 28.06 Million USD | -531.007% |
NeuroMetrix, Inc. | 11.09 Million USD | -1495.577% |
Hyperfine, Inc. | 52.87 Million USD | -234.945% |
Establishment Labs Holdings Inc. | 172 Million USD | -2.959% |
Biomerica, Inc. | 6.97 Million USD | -2437.862% |
Bone Biologics Corporation | 9.42 Million USD | -1778.302% |
AVITA Medical, Inc. | 80.77 Million USD | -119.23% |
Bluejay Diagnostics, Inc. | 10.31 Million USD | -1617.47% |
Silk Road Medical, Inc | 186.35 Million USD | 4.972% |